KR20240056488A - 자연적 책임-면제 cdr을 사용한 항체 친화성 성숙 - Google Patents

자연적 책임-면제 cdr을 사용한 항체 친화성 성숙 Download PDF

Info

Publication number
KR20240056488A
KR20240056488A KR1020247004521A KR20247004521A KR20240056488A KR 20240056488 A KR20240056488 A KR 20240056488A KR 1020247004521 A KR1020247004521 A KR 1020247004521A KR 20247004521 A KR20247004521 A KR 20247004521A KR 20240056488 A KR20240056488 A KR 20240056488A
Authority
KR
South Korea
Prior art keywords
sequence
antibody
cdr3
cdr1
cdr2
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
KR1020247004521A
Other languages
English (en)
Korean (ko)
Inventor
앤드류 레이먼 모튼 브래드버리
사라 디안젤로
안드레 텍세라
Original Assignee
룰즈-베이스드 메디신 인크.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 룰즈-베이스드 메디신 인크. filed Critical 룰즈-베이스드 메디신 인크.
Publication of KR20240056488A publication Critical patent/KR20240056488A/ko
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/46—Hybrid immunoglobulins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/005—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies constructed by phage libraries
    • C—CHEMISTRY; METALLURGY
    • C40—COMBINATORIAL TECHNOLOGY
    • C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B40/00—Libraries per se, e.g. arrays, mixtures
    • C40B40/04—Libraries containing only organic compounds
    • C40B40/10—Libraries containing peptides or polypeptides, or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C40—COMBINATORIAL TECHNOLOGY
    • C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B50/00—Methods of creating libraries, e.g. combinatorial synthesis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/40—Immunoglobulins specific features characterized by post-translational modification
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/40—Immunoglobulins specific features characterized by post-translational modification
    • C07K2317/41—Glycosylation, sialylation, or fucosylation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C07K2317/565—Complementarity determining region [CDR]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C07K2317/569—Single domain, e.g. dAb, sdAb, VHH, VNAR or nanobody®
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
    • C07K2317/92—Affinity (KD), association rate (Ka), dissociation rate (Kd) or EC50 value

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Peptides Or Proteins (AREA)
KR1020247004521A 2021-07-07 2022-07-07 자연적 책임-면제 cdr을 사용한 항체 친화성 성숙 Pending KR20240056488A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163218919P 2021-07-07 2021-07-07
US63/218,919 2021-07-07
PCT/US2022/036422 WO2023283383A1 (en) 2021-07-07 2022-07-07 Antibody affinity maturation using natural liability-free cdrs

Publications (1)

Publication Number Publication Date
KR20240056488A true KR20240056488A (ko) 2024-04-30

Family

ID=84801095

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020247004521A Pending KR20240056488A (ko) 2021-07-07 2022-07-07 자연적 책임-면제 cdr을 사용한 항체 친화성 성숙

Country Status (6)

Country Link
US (2) US20230167165A1 (https=)
EP (1) EP4366773A4 (https=)
JP (1) JP2024523730A (https=)
KR (1) KR20240056488A (https=)
CN (1) CN118103065A (https=)
WO (1) WO2023283383A1 (https=)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8877688B2 (en) * 2007-09-14 2014-11-04 Adimab, Llc Rationally designed, synthetic antibody libraries and uses therefor
EP3246434A1 (en) * 2015-01-13 2017-11-22 Ewha University-Industry Collaboration Foundation Method for preparing novel antibody library and library prepared thereby
EP3728705A4 (en) * 2017-12-18 2022-01-19 Charles River Laboratories, Inc. RADICALLY DIVERSE HUMAN ANTIBODY LIBRARY
EP3833685A4 (en) * 2018-07-08 2022-08-17 Specifica Inc. ANTIBODY LIBRARIES WITH FEATURES FOR MAXIMIZED ANTIBODY DEVELOPMENT

Also Published As

Publication number Publication date
US20230167165A1 (en) 2023-06-01
JP2024523730A (ja) 2024-06-28
EP4366773A1 (en) 2024-05-15
WO2023283383A1 (en) 2023-01-12
CN118103065A (zh) 2024-05-28
EP4366773A4 (en) 2025-11-05
US20240384438A1 (en) 2024-11-21

Similar Documents

Publication Publication Date Title
Wark et al. Latest technologies for the enhancement of antibody affinity
US8633139B2 (en) Methods of screening complex protein libraries to identify altered properties
US20240240360A1 (en) Antibody libraries with maximized antibody developability characteristics
Shi et al. De novo selection of high-affinity antibodies from synthetic fab libraries displayed on phage as pIX fusion proteins
Teixeira et al. Simultaneous affinity maturation and developability enhancement using natural liability-free CDRs
US12442107B2 (en) Single domain antibody libraries with maximized antibody developability characteristics
US20240384438A1 (en) Antibody affinity maturation using natural liability-free cdrs
US11725306B2 (en) Antibody fragment library, and uses thereof
US20230295271A1 (en) Methods and compositions for in vitro affinity maturation of monoclonal antibodies

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20240207

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
P11 Amendment of application requested

Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P11-NAP-X000 (AS PROVIDED BY THE NATIONAL OFFICE)